{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:34:12Z","timestamp":1777937652443,"version":"3.51.4"},"reference-count":29,"publisher":"Medical Association of Nippon Medical School","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2026,4,20]]},"DOI":"10.1272\/jnms.jnms.2026_93-210","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:15:19Z","timestamp":1777587319000},"page":"161-172","source":"Crossref","is-referenced-by-count":0,"title":["Midazolam and Dexmedetomidine Promoted Migration of Human Lung Adenocarcinoma A549 Cells"],"prefix":"10.1272","volume":"93","author":[{"given":"Anna","family":"Ishikawa","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masae","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tomihari","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","unstructured":"1. Ministry of health, Labour and Welfare (JP), Cancer and Disease Control Division. [Cancer incidence of Japan 2020] [Internet]. Tokyo: Ministry of health, Labour and Welfare, Cancer and Disease Control Division; 2020. Available from: https:\/\/www.mhlw.go.jp\/content\/10900000\/001231386.pdf. Japanese."},{"key":"2","unstructured":"2. Japan Lung Cancer Society. [Lung cancer treatment guidelines - including malignant pleural mesothelioma and thymic tumors 2022 edition] [Internet]. Tokyo: Japan Lung Cancer Society; 2022. Available from: https:\/\/www.haigan.gr.jp\/guideline\/2022\/index.html. Japanese."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Iwasaki M, Edmondson M, Sakamoto A, Ma D. Anesthesia, surgical stress, and &quot;long-term&quot; outcomes. Acta Anaesthesiol Taiwan [Internet]. 2015 Sep;53 (3):99-104. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26235899","DOI":"10.1016\/j.aat.2015.07.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ishikawa M, Iwasaki M, Sakamoto A, Ma D. Anesthetics may modulate cancer surgical outcome: a possible role of miRNAs regulation. BMC Anesthesiol [Internet]. 2021 Mar 9;21 (1):71. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33750303","DOI":"10.1186\/s12871-021-01294-w"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Wigmore TJ, Mohammed K, Jhanji S. Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery: a retrospective analysis. Anesthesiology [Internet]. 2016 Jan;124 (1):69-79. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26556730","DOI":"10.1097\/ALN.0000000000000936"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dou Y, Li Y, Chen J, et al. Inhibition of cancer cell proliferation by midazolam by targeting transient receptor potential melastatin 7. Oncol Lett [Internet]. 2013 Mar;5 (3):1010-6. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23426784","DOI":"10.3892\/ol.2013.1129"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Qi Y, Yao X, Du X. Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing PIM-1. IUBMB Life [Internet]. 2020 Mar;72 (3):452-64. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31651086","DOI":"10.1002\/iub.2171"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Iwasaki M, Yamamoto M, Tomihari M, Ishikawa M. Ropivacaine administration suppressed A549 lung adenocarcinoma cell proliferation and migration via ACE2 upregulation and inhibition of the Wnt1 pathway. Int J Mol Sci [Internet]. 2024 Aug 28;25 (17):9334. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/39273283","DOI":"10.3390\/ijms25179334"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Talib HK, Dobesova Z, Klir P, et al. Association of red blood cell sodium leak with blood pressure in recombinant inbred strains. Hypertension [Internet]. 1992 Oct;20 (4):575-82. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1398893","DOI":"10.1161\/01.HYP.20.4.575"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Chen HY, Li GH, Tan GC, et al. Dexmedetomidine enhances hypoxia-induced cancer cell progression. Exp Ther Med [Internet]. 2019 Dec;18 (6):4820-8. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31772647","DOI":"10.3892\/etm.2019.8136"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wang C, Datoo T, Zhao H, et al. Midazolam and dexmedetomidine affect neuroglioma and lung carcinoma cell biology in vitro and in vivo. Anesthesiology [Internet]. 2018 Nov;129 (5):1000-14. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30157038","DOI":"10.1097\/ALN.0000000000002401"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lu HL, Wu KC, Chen CW, et al. Anticancer effects of midazolam on lung and breast cancers by inhibiting cell proliferation and epithelial-mesenchymal transition. Life (Basel) [Internet]. 2021 Dec 13;11 (12):1396. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34947927","DOI":"10.3390\/life11121396"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tam SY, Wu VWC, Law HKW. Hypoxia-induced epithelial-mesenchymal transition in cancers: HIF-1\u03b1 and beyond. Front Oncol [Internet]. 2020;10:486. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32322559","DOI":"10.3389\/fonc.2020.00486"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Huang H. Matrix Metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: Recent advances. Sensors (Basel) [Internet]. 2018 Sep 27;18 (10):3249. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30262739","DOI":"10.3390\/s18103249"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Vu TH, Shipley JM, Bergers G, et al. MMP-9\/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell [Internet]. 1998 May 1;93 (3):411-22. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9590175","DOI":"10.1016\/S0092-8674(00)81169-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Itoh T, Tanioka M, Matsuda H, et al. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis [Internet]. 1999 Mar;17 (2):177-81. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10411111","DOI":"10.1023\/A:1006603723759"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Zeng ZS, Cohen AM, Guillem JG. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis [Internet]. 1999 May;20 (5):749-55. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10334190","DOI":"10.1093\/carcin\/20.5.749"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zhang Y, Wang X. Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer. J Hematol Oncol [Internet]. 2020 Dec 4;13 (1):165. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33276800","DOI":"10.1186\/s13045-020-00990-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sadot E, Geiger B, Oren M, Ben-Ze&apos;ev A. Down-regulation of beta-catenin by activated p53. Mol Cell Biol [Internet]. 2001 Oct;21 (20):6768-81. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11564862","DOI":"10.1128\/MCB.21.20.6768-6781.2001"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. He S, Tang S. WNT\/\u03b2-catenin signaling in the development of liver cancers. Biomed Pharmacother [Internet]. 2020 Dec;132:110851. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33080466","DOI":"10.1016\/j.biopha.2020.110851"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Goddette DW, Frieden C. Actin polymerization. The mechanism of action of cytochalasin D. J Biol Chem [Internet]. 1986 Dec 5;261 (34):15974-80. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3023337","DOI":"10.1016\/S0021-9258(18)66662-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Zhang Q, Lu S, Li T, et al. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa\/VEGFR2\/ERK pathway. J Exp Clin Cancer Res [Internet]. 2019 Apr 25;38 (1):173. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31023337","DOI":"10.1186\/s13046-019-1156-5"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Tomihari M, Iwasaki M, Ishikawa M. Propranolol and landiolol inhibit cell proliferation enhanced by noradrenaline in human lung adenocarcinoma cells. Biomed Res [Internet]. 2024;45 (6):253-9. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/39581614","DOI":"10.2220\/biomedres.45.253"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Liu T, Zhu J, Du W, et al. AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma. Respir Res [Internet]. 2020 Sep 1;21 (1):227. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32873299","DOI":"10.1186\/s12931-020-01491-0"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Gobbi G, Grieco A, Torricelli F, et al. The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling. Cell Death Dis [Internet]. 2023 Nov 18;14 (11):752. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37980331","DOI":"10.1038\/s41419-023-06277-y"},{"key":"26","unstructured":"26. Manios K, Tsiambas E, Stavrakis I, et al. c-Fos\/c-Jun transcription factors in non-small cell lung carcinoma. J BUON [Internet]. 2020 Sep-Oct;25 (5):2141-3. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33277827"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Munro AJ, Lain S, Lane DP. P53 abnormalities and outcomes in colorectal cancer: a systematic review. Br J Cancer [Internet]. 2005 Feb 14;92 (3):434-44. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15668707","DOI":"10.1038\/sj.bjc.6602358"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Wang R, Wang X, Zhang J, Liu Y. LINC00942 promotes tumor proliferation and metastasis in lung adenocarcinoma via FZD1 upregulation. Technol Cancer Res Treat [Internet]. 2021 Jan-Dec;20:1533033820977526. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34253104","DOI":"10.1177\/1533033820977526"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Park T. Crk and CrkL as therapeutic targets for cancer treatment. Cells [Internet]. 2021 Mar 27;10 (4):739. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33801580","DOI":"10.3390\/cells10040739"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/2\/93_JNMS.2026_93-210\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:11:17Z","timestamp":1777695077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/2\/93_JNMS.2026_93-210\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2026_93-210","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"JNMS.2026_93-210"}}